Xing Xie

11PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 06, 2023
The Role of Perioperative C-Reactive Protein in Predicting the Prognosis of Epithelial Ovarian Carcinoma.

Qianqian Pan, Mingjing Wei, Mengyi Lu

|Jan 20, 2023
Molecular profile-based recommendations for postoperative adjuvant therapy in early endometrial cancer with high-intermediate or intermediate risk: a Chinese randomized phase III trial (PROBEAT).

Yang Li, Changkun Zhu, Hongyu Xie

|Jan 02, 2023
The effect of prophylactic chemotherapy on treatment outcome of postmolar gestational trophoblastic neoplasia.

Yuanyuan Liu, Yaqiong Ye, Xiaodong Cheng

|May 28, 2021
Potential of peptide-engineered exosomes with overexpressed miR-92b-3p in anti-angiogenic therapy of ovarian cancer.

Jiaying Wang, Conghui Wang, Yang Li

|Mar 17, 2021
LncRNA SPOCD1-AS from ovarian cancer extracellular vesicles remodels mesothelial cells to promote peritoneal metastasis via interacting with G3BP1.

Conghui Wang, Jiaying Wang, Xiameng Shen

|May 28, 2020
Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists.

Yingmei Wang, Shiqian Zhang, Lihui Wei

Pageof 2

Frequent Collaborators

5 joint publications

Xinyu Wang

3 joint publications

Xiao Li

3 joint publications

Weiguo Lu

2 joint publications

Yaping Xu